FDA Inspection
NuCare Pharmaceuticals IncNuCare Pharmaceuticals Inc – FDA Inspection, Jan 10, 2020
Record Details
This FDA Inspection record concerns NuCare Pharmaceuticals Inc, with an inspection on January 10, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- NuCare Pharmaceuticals Inc
- Inspection Date
- January 10, 2020
- Product Type
- Drugs
View Company Profile
ID · 10375d6a-fc6d-497d-a65f-1fb9604d8b98
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1114915
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.137(a)Expiration date lacking
Full citation text and observation details available on the Dashboard.
Other FDA inspections of NuCare Pharmaceuticals Inc
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 12, 2025 | Not classified | Los Angeles District Office | |
| September 19, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 21, 2018 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| February 13, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 31, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for NuCare Pharmaceuticals Inc
- FDA Inspection 1264447 - 2025-03-12
- FDA Inspection 1069414 - 2018-09-19
- FDA Inspection 1045177 - 2018-03-21
- FDA Inspection 920340 - 2015-02-13
- FDA Inspection 718535 - 2011-03-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.